Pharmaceutical Trademarks At PTMG Autumn Conference - Berlin 2019

Daniel Comerford,

Did you know that in 2018 worldwide revenue in the Pharma industry exceeded $1.1 trillion? With this kind of prolific activity the screening and clearance of Pharma trademarks and brand protection demands strong and efficient team work. Our Pharma clients rely on a fast, intuitive and collaborative solution to enable their marketing, branding agencies, regulatory experts and trademark attorneys to work together when launching new products into the marketplace.

We took the opportunity to meet and connect with our many Pharma clients and trademark professionals last week at the Pharmaceuticals Trade Marks Group Autumn Conference in Berlin. The 99th PTMG Conference was held at the Intercontinental Hotel from October 2nd - 5th. The event was a huge success and was at capacity and the 800 or so delegates attended a diverse and interesting programme of talks delivered over a 2 day period, which was outlined in detail on the PTMG Conference website.

Opening Day

The conference was opened formally by the Chairman, Frank Meixner (Bayer Intellectual Property), followed by a round up of international cases by Michael Hawkins (Noerr). Tom Hannah of GSK then gave a founders lecture which covered the nuances of the Sky v Skykick case.

Wiebke Baars and Manje Epping (Taylor Wessing) spoke about botanicals and gave the delegates an update on regulatory status, health claims and trademarks. They were followed by Scott Jolliffe of Gowling WLG. Jolliffee discussed the new U.S.-Mexico-Canada Agreement (USCMA) which is replacing The North American Free Trade Agreement and looked at whether the new agreement could actually lead to fairer trade.

After a light lunch Tara Aaron (Aaron Sanders PLLC) gave us her insights on the topical issue of data privacy in her talk on “New Challenges for the Pharma industry and their brands”. Then André Maré of ENSAfrica gave attendees his expert take on best practice in managing a pharmaceutical trade mark portfolio in Africa.

Day 1 ended with a spotlight on “Fighting Counterfeit and Diverted Medicines in and from Turkey” led by Baris Kalayci (Gün & Partners).

Final Day

The second day of the conference was opened again by Frank Meixner, Chairman. Next, Oliver Wehnert (EY) addressed delegates with an overview of IP Tax Strategies. He was followed by Alexander Loh of Merck who continued this theme with his talk on the Implementation of IP Tax Strategies on licence contracts.

After a short coffee break, a spotlight session on China ensued. Ling Zhao, of the China Council for the Promotion of International Trade (CCPIT), delivered a fascinating insight into well known trademarks and bad faith applications. He was followed by Aaron Hurvitz (Kangxin Partners) who spoke about the linguistics and regulatory regime in China.

After a working lunch the conference continued with an overview by Florian Drücke of the German Music Industry Federation on “Securing a level playing field in the EU with the new Copyright Directive”. Drücke was followed by Gustavo Piva de Andrade (Dannemann Siemsen) who discussed software disputes in the pharmaceutical Industry. Rachel Cockburn-Buhl of Ferring closed the conference speaker programme with her profile of an in-house trademark attorney. The event was formally brought to a close with remarks by Frank Meixner, PTMG’s Chairman.

Social Programme

Opportunities to network and mingle informally were offered every day with a thoughtful and well-planned “after event” social programme. This consisted of a welcome cocktail party, an informal evening at the Arminius Market Hall and, on the final evening, a spectacular Gala dinner-dance at Charlottenburg Palace, a Baroque palace in the host city of Berlin.

Thank You

We would like to take this opportunity to thank here the many clients, trademark professionals and acquaintances who took the time to visit our stand. And, thank you to all the PTMG Committee members and officers, namely, Derek Rossitter, Lesley Edwards and Vanessa Parker, for organizing such a successful conference. We look forward to returning to PTMG (London) in the Spring of 2020 to help PTMG to mark their 100th conference!

USPTO and EUIPO Pharma Series

We have put together a short series of publications to support Pharma trademark professionals.
Our webinar on effective management of trademarks and complementary report on “Trademark Activity in the Pharmaceutical Industry” will give you new insights into the Pharma sector.


Tiffany Walter, Head of Pharma Trademarks at F. Hoffmann-La Roche AG joins Trademark Specialist, Zac Casstevens in a discussion on effective management of trademarks in the Pharma industry. During the webinar we share our data insights into recent Pharma trademark activity in the USPTO and the EUIPO. Tiffany Walter expands on the main challenges of of trademark management, including issues related to trademark screening and filing, as well as brand protection.

Complementary report

Our report on “Trademark Activity in the Pharmaceutical Industry” includes a more detailed overview of the Pharma data presented in the webinar with additional data analysis in Pharma-related Nice classes 1,3, 5, 10 and 44 and also includes commentary from our trademark analysts.

New call-to-action

By Daniel Comerford
Daniel Comerford, Trademark Executive at Trademarknow, works with our product and development team to share feedback from our customers to ensure that they always get the best results for their business from our platform. Outside of work he enjoys cycling, when the Irish weather obliges!